multiBic 4 mmol/l potassium is indicated for intravenous use as substitution solution in haemofiltration and haemodiafiltration, and as dialysis solution in haemodialysis and haemodiafiltration.For use in patients - with acute kidney injury requiring continuous renal replacement therapy: continuous haemodialysis, haemofiltration or haemodiafiltration treatments. - with chronic kidney disease in whom a transient treatment is indicated, e.g. during the stay on an intensive care unit.- when continuous renal replacement therapy is indicated as part of the treatment of an intoxication with water soluble, filterable/dialyzable toxins.multiBic 4 mmol/l potassium is indicated in adults.